On November 8, CPE4H hosted its first inaugural symposium, which showcased current innovative work from the members of the Center at Penn, and also research from scientists at The University of Washington, Duke University and Northwestern University.
Researchers led by Michael Mitchell of the University of Pennsylvania are broaching the blood-brain barrier by
using lipid nanoparticles (LNPs) to deliver mRNA, offering new hope for treating medical conditions.
A research team led by Michael Mitchell, associate professor in the School of Engineering and Applied Science at the University of Pennsylvania, has found a solution that could help CAR T therapies reach their full potential while minimizing severe side effects.
